I agree 100% with what this person from another forum says:
I suspect that they will get the 50%+1 by Jan 21st. With the biotech market tanking hard and capital drying up it seems unlikely to me that Astellas will need to up the offer. I would bet that the Ocata insiders are hoping more than ever that the deal goes through. The prospects for raising funds on their own have diminished considerably in the last couple of weeks.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.